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Effects of momordica charantiaon pancreatic histopathological changes associated with 
streptozotocin-induced diabetes in neonatal rats. 
 
ABSTRACT 
The aim of this research was to determine the effects of Momordica charantia (MC) fruit 
aqueous extract on pancreatic histopathological changes in neonatal STZ-induced type-II 
diabetic rats. Diabetes mellitus was induced in one day Sprague-Dawley neonatal rats using a 
single intrapretoneal injection of streptozotocin (STZ) (85 mg/kg body weight) and 
monitored for 12 weeks thereafter. The diabetic rats were separated into three groups, as 
follows: the diabetic control group (i.e. nSTZ), the diabetic group (i.e. nSTZ/M) - which was 
orally given 20 mg/kg of MC fruit extract, and the diabetic group (i.e. nSTZ/G) - that was 
treated with glibenclamide, 0.1 mg/kg for a period of four weeks. At the end of treatment, the 
animals were sacrificed and blood samples were collected from the saphenous vein to 
measure the blood glucose and serum insulin level. The pancreatic specimens were removed 
and processed for light microscopy, electron microscopy examination and 
immunohistochemical study. The results of this study showed that MC fruit aqueous extract 
reduced the blood glucose level as well as glibenclamide and increased the serum insulin 
level in the treated diabetic rats (P<0.05). The fruit extract of MC alleviated pancreatic 
damage and increased the number of ß-cells in the diabetic treated rats (P<0.05). Our results 
suggest that oral feeding of MC fruit extract may have a significant role in the renewal of 
pancreatic ß-cells in the nSTZ rats. 
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